Myocardial Remodeling in Hypertension: Toward a New View of Hypertensive Heart Disease

被引：139
作者：
Gonzalez, Arantxa [1 ,2 ,3 ]
Ravassa, Susana [1 ,2 ,3 ]
Lopez, Begona [1 ,2 ,3 ]
Moreno, Maria U. [1 ,2 ,3 ]
Beaumont, Javier [1 ,2 ,3 ]
San Jose, Gorka [1 ,2 ,3 ]
Querejeta, Ramon [4 ]
Bayes-Genis, Antoni [3 ,5 ,6 ,7 ]
Diez, Javier [1 ,2 ,3 ,8 ,9 ]
机构：
[1] Univ Navarra, Ctr Appl Med Res, Program Cardiovasc Dis, Ave Pio 12,55, Pamplona 31008, Spain
[2] Inst Invest Sanitaria Navarra IDISNA, Pamplona, Spain
[3] Carlos III Inst Hlth, CIBERCV, Madrid, Spain
[4] Univ Basque Country, Donostia Univ Hosp, Div Cardiol, San Sebastian, Spain
[5] Hosp Badalona Germans Trias & Pujol, Heart Failure Unit, Badalona, Spain
[6] Hosp Badalona Germans Trias & Pujol, Cardiol Serv, Badalona, Spain
[7] Univ Autonoma Barcelona, Dept Med, Barcelona, Spain
[8] Univ Navarra, Univ Navarra Clin, Dept Cardiol & Cardiac Surg, Pamplona, Spain
[9] Univ Navarra, Univ Navarra Clin, Dept Nephrol, Pamplona, Spain
来源：
HYPERTENSION | 2018年 / 72卷 / 03期
关键词：
LEFT-VENTRICULAR HYPERTROPHY; REGULATORY T-CELLS; PRESERVED EJECTION FRACTION; PATHOLOGICAL CARDIAC-HYPERTROPHY; CORONARY FLOW RESERVE; C-REACTIVE PROTEIN; DIASTOLIC DYSFUNCTION; ARTERIAL-HYPERTENSION; GENE-EXPRESSION; BLOOD-PRESSURE;
D O I：
10.1161/HYPERTENSIONAHA.118.11125
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
[No abstract available]
引用
收藏
页码：549 / 558
页数：10
相关论文
共 104 条
[1]   The CXCL10/CXCR3 Axis and Cardiac Inflammation: Implications for Immunotherapy to Treat Infectious and Noninfectious Diseases of the Heart [J].
Altara, Raffaele ;
Mallat, Ziad ;
Booz, George W. ;
Zouein, Fouad A. .
JOURNAL OF IMMUNOLOGY RESEARCH, 2016, 2016
[2]   Coronary reserve impairment prevents the improvement of left ventricular dysfunction and adversely affects the long-term outcome of patients with hypertensive dilated cardiomyopathy [J].
Angelim Pereira, Valeria Fontenelle ;
Frimm, Clovis de Carvalho ;
Tudi Rodrigues, Ana Clara ;
Statistician, Mariana Curi .
JOURNAL OF THE AMERICAN SOCIETY OF HYPERTENSION, 2010, 4 (01) :14-21
[3]   Discovering cardiac pericyte biology: From physiopathological mechanisms to potential therapeutic applications in ischemic heart disease [J].
Avolio, Elisa ;
Madeddu, Paolo .
VASCULAR PHARMACOLOGY, 2016, 86 :53-63
[4]   Regression of electrocardiographic left ventricular hypertrophy or strain is associated with lower incidence of cardiovascular morbidity and mortality in hypertensive patients independent of blood pressure reduction - A LIFE review [J].
Bang, Casper N. ;
Devereux, Richard B. ;
Okin, Peter M. .
JOURNAL OF ELECTROCARDIOLOGY, 2014, 47 (05) :630-635
[5]   Independent association between inflammatory markers (C-reactive protein, interleukin-6, and TNF-α) and essential hypertension [J].
Bautista, LE ;
Vera, LM ;
Arenas, IA ;
Gamarra, G .
JOURNAL OF HUMAN HYPERTENSION, 2005, 19 (02) :149-154
[6]   Eprosartan improves cardiac performance, reduces cardiac hypertrophy and mortality and downregulates myocardial monocyte chemoattractant protein-1 and inflammation in hypertensive heart disease [J].
Behr, TM ;
Willette, RN ;
Coatney, RW ;
Berova, M ;
Angermann, CE ;
Anderson, K ;
Sackner-Bernstein, JD ;
Barone, FC .
JOURNAL OF HYPERTENSION, 2004, 22 (03) :583-592
[7]   ECM remodeling in hypertensive heart disease [J].
Berk, Bradford C. ;
Fujiwara, Keigi ;
Lehoux, Stephanie .
JOURNAL OF CLINICAL INVESTIGATION, 2007, 117 (03) :568-575
[8]   Blood pressure, C-reactive protein, and risk of future cardiovascular events [J].
Blake, GJ ;
Rifai, N ;
Buring, JE ;
Ridker, PM .
CIRCULATION, 2003, 108 (24) :2993-2999
[9]   Lisinopril-mediated regression of myocardial fibrosis in patients with hypertensive heart disease [J].
Brilla, CG ;
Funck, RC ;
Rupp, H .
CIRCULATION, 2000, 102 (12) :1388-1393
[10]   IMPAIRED DIASTOLIC FUNCTION AND CORONARY RESERVE IN GENETIC-HYPERTENSION - ROLE OF INTERSTITIAL FIBROSIS AND MEDIAL THICKENING OF INTRAMYOCARDIAL CORONARY-ARTERIES [J].
BRILLA, CG ;
JANICKI, JS ;
WEBER, KT .
CIRCULATION RESEARCH, 1991, 69 (01) :107-115
12345678910